Preclinical Evidence of Ghrelin as a Therapeutic Target in Epilepsy
Oncotarget - United States
doi 10.18632/oncotarget.18349
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 2, 2017
Authors
Publisher
Impact Journals, LLC
Available in full text
June 2, 2017
Impact Journals, LLC